Filing Details

Accession Number:
0000899243-22-021350
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-07 16:37:05
Reporting Period:
2022-06-03
Accepted Time:
2022-06-07 16:37:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1765253 Versant Vantage I, L.p. One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1777651 Versant Vantage I Gp, L.p. One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
1777653 Versant Vantage I Gp-Gp, Llc One Sansome Street
Suite 3630
San Francisco CA 94104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2022-06-03 250,000 $12.25 2,344,451 No 4 S Indirect See Footnote
Common Shares Disposition 2022-06-03 438,795 $12.25 1,464,875 No 4 S Indirect See Footnote
Common Shares Disposition 2022-06-03 13,199 $12.25 44,065 No 4 S Indirect See Footnote
Common Shares Disposition 2022-06-03 14,611 $12.25 48,776 No 4 S Indirect See Footnote
Common Shares Disposition 2022-06-03 33,395 $12.25 111,484 No 4 S Indirect See Footnote
Common Shares Disposition 2022-06-06 614,315 $0.00 850,560 No 4 J Indirect See Footnote
Common Shares Acquisiton 2022-06-06 132,692 $0.00 132,692 No 4 J Indirect See Footnote
Common Shares Disposition 2022-06-06 18,478 $0.00 25,587 No 4 J Indirect See Footnote
Common Shares Acquisiton 2022-06-06 3,992 $0.00 136,684 No 4 J Indirect See Footnote
Common Shares Disposition 2022-06-06 20,454 $0.00 28,322 No 4 J Indirect See Footnote
Common Shares Acquisiton 2022-06-06 4,419 $0.00 141,103 No 4 J Indirect See Footnote
Common Shares Disposition 2022-06-06 141,103 $0.00 0 No 4 J Indirect See Footnote
Common Shares Disposition 2022-06-06 46,753 $0.00 64,731 No 4 J Indirect See Footnote
Common Shares Acquisiton 2022-06-06 10,099 $0.00 10,099 No 4 J Indirect See Footnote
Common Shares Disposition 2022-06-06 10,099 $0.00 0 No 4 J Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
No 4 J Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 231,211 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.25 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. Shares held by Versant Venture Capital VI, L.P. ("VVC VI"). Versant Ventures VI GP-GP, LLC ("VV VI GP") is the sole general partner of Versant Ventures VI GP, L.P. ("VV VI") and VV VI is the sole general partner of VVC VI. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV VI GP and may be deemed to share voting and dispositive power over the shares held by VVC VI. Each of VV VI GP, VV VI and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC VI, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  3. Shares held by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VVC V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  4. Shares held by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VAF V. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VAF V, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  5. Shares held by Versant Ophthalmic Affiliates Fund I, L.P. ("VOAF I"). VV V is the sole general partner of VOAF I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VOAF I. Each of VV V and Jerel C. Davis disclaims beneficial ownership of the shares held by VOAF I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  6. Shares held by Versant Venture Capital V (Canada) LP ("VVC V (Canada)"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V (Canada) GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V (Canada)") and VV V (Canada) is the sole general partner of VVC V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VVC V (Canada). Each of VV V (Canada), VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VVC V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  7. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V to its partners.
  8. Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V.
  9. Shares held by VV V. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV V and may be deemed to share voting and dispositive power over the shares held by VV V; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  10. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VAF V to its partners.
  11. Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VAF V.
  12. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VOAF I to its partners.
  13. Represents a change in the form of ownership of VV V by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VOAF I.
  14. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V, to its members.
  15. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VVC V (Canada) to its partners.
  16. Represents a change in the form of ownership of VV V (Canada) by virtue of the receipt of shares in the pro-rata in-kind distribution of common shares of the Issuer for no consideration by VVC V (Canada).
  17. Shares held by VV V (Canada). VV V (Canada) GP is the sole general partner of VV V (Canada). Jerel C. Davis, a member of the Issuer's board of directors, is a director of VV V (Canada) GP and may be deemed to share voting and dispositive power over the shares held by VV V (Canada). Each of VV V (Canada) GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV V (Canada), except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.
  18. Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV V (Canada), to its partners.
  19. Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("VV I GP") and VV I GP is the sole general partner of VV I. Jerel C. Davis, a member of the Issuer's board of directors, is a managing director of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I. Each of VV I GP-GP, VV I GP and Jerel C. Davis disclaims beneficial ownership of the shares held by VV I, except to the extent of their respective pecuniary interests therein. Jerel C. Davis is a director of the Issuer and, accordingly files separate Section 16 reports.